Total: 7 |
|
PMID (PMCID) | ||
---|---|---|
30949369 |
OTHER | |
Development of Multiple Myeloma of the IgA Type in a Patient with Cold Agglutinin Disease: Transformation or Coincidence? | ||
Sefland O, Randen U, Berentsen S. Case Rep Hematol. 2019;2019:1610632. |
||
Cold agglutinin disease (CAD) is an autoimmune hemolytic anemia and a distinct, clonal bone marrow lymphoproliferative disorder, characterized in most cases by a monoclonal IgM954 serum protein. | ||
29991541 |
FEMALE | |
Cold agglutinin-mediated autoimmune haemolytic anaemia associated with diffuse large B cell lymphoma. | ||
Wongsaengsak S, Czader M, Suvannasankha A. BMJ Case Rep. 2018;2018:. |
||
While primary cold agglutinin disease is an idiopathic lymphoproliferative disorder, secondary cold agglutinin syndrome (CAS) complicates other diseases such as infections, autoimmune diseases and cancers, mostly low-grade lymphomas. | ||
29991541 |
FEMALE | |
Cold agglutinin-mediated autoimmune haemolytic anaemia associated with diffuse large B cell lymphoma. | ||
Wongsaengsak S, Czader M, Suvannasankha A. BMJ Case Rep. 2018;2018:. |
||
While primary cold agglutinin disease is an idiopathic lymphoproliferative disorder, secondary cold agglutinin syndrome (CAS) complicates other diseases such as infections, autoimmune diseases and cancers, mostly low-grade lymphomas. | ||
28487302 |
FEMALE | |
Prophylactic use of eculizumab during surgery in chronic cold agglutinin disease. | ||
Tjonnfjord E, Vengen OA, Berentsen S, Tjonnfjord GE. BMJ Case Rep. 2017;2017:. |
||
Primary chronic cold agglutinin disease (CAD) is an autoimmune haemolytic anaemia in which a specific bone marrow lymphoproliferative disorder causes production of cold agglutinins (CA). | ||
12888170 |
MIXED_SAMPLE | Middle Aged |
[Rituximab in cold agglutinin disease]. | ||
Camou F, Viallard JF, Pellegrin JL. Rev Med Interne. 2003;24(8):501-4. |
||
Cold agglutinin disease is a chronic auto-immune hemolytic anemia related to a lymphoproliferative disorder with a degenerative potential and no codified treatment. | ||
8296193 |
FEMALE | Middle Aged |
[Treatment of severe idiopathic cold-agglutinin diseases using interferon-alpha 2b]. | ||
Rordorf R, Barth A, Nydegger U, Tobler A. Schweiz Med Wochenschr. 1994;124(1-2):56-61. |
||
Based on in vitro evidence, primary cold agglutinin disease can be considered as a low grade malignant lymphoproliferative disorder in which interferon-alpha has been shown to be an effective therapeutic agent, at least in forms such as hairy cell leukemia. | ||
3344409 |
MIXED_SAMPLE | |
[Idiopathic cold agglutinin disease. Clinical aspects, therapy and course in 6 patients]. | ||
Budmiger H, Rhyner K, Siegenthaler-Zuber G, Bollinger A. Schweiz Med Wochenschr. 1988;118(2):52-7. |
||
One patient developed a lymphoproliferative disorder 11 years after diagnosis of idiopathic chronic cold agglutinin disease. |